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Abstract Thymosin L4 possesses actin-sequestering activity
and, like transglutaminases, is supposed to be involved in cellular
events like angiogenesis, blood coagulation, apoptosis and wound
healing. Thymosin L4 serves as a specific glutaminyl substrate for
transglutaminase and can be fluorescently labeled with dansyl-
cadaverine. Two (Gln-23 and Gln-36) of the three glutamine
residues were mainly involved in the transglutaminase reaction,
while the third glutaminyl residue (Gln-39) was derivatized with a
low efficiency. Labeled derivatives were able to inhibit poly-
merization of G-actin and could be cross-linked to G-actin by 1-
ethyl-3-[3-(dimethylamino)propyl]carbodiimide. Fluorescently
labeled thymosin L4 may serve as a useful tool for further
investigations in cell biology. Thymosin L4 could provide a
specific glutaminyl substrate for transglutaminase in vivo,
because of the fast reaction observed in vitro occurring at
thymosin L4 concentrations which are found inside cells. Taking
these data together, it is tempting to speculate that thymosin L4
may serve as a glutaminyl substrate for transglutaminases in vivo
and play an important role in transglutaminase-related processes.
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1. Introduction
Actin is present at high concentrations in virtually every
eukaryotic cell. About half of the intracellular actin is stabi-
lized in its monomeric form (G-actin) by interaction with
sequestering factors [1]. This monomeric actin can be used
for fast generation of new actin ¢laments after an appropriate
intra- or extracellular signal [2]. The L-thymosins are a family
of highly conserved polar 5 kDa peptides that are present in
many tissues and cells of di¡erent vertebrates except human
and chicken erythrocytes ([3], unpublished data). The most
abundant species of L-thymosins in mammalian tissues is thy-
mosin L4, which was originally supposed to be a thymic hor-
mone [4,5]. Safer and coworkers demonstrated in 1991 that
thymosin L4 is identical to the actin-sequestering factor Fx
[6,7]. Thymosin L4 is now regarded as the main intracellular
G-actin-sequestering peptide in most mammalian cells [8^10]
and it forms a 1:1 complex with G-actin, thereby inhibiting
salt-induced polymerization to F-actin [11^15].
We had found that thymosin L4 is present in very high
concentrations in blood cells, with the exception of erythro-
cytes [3]. The concentration of thymosin L4 in serum is nor-
mally low, but increases if the serum is not immediately re-
moved from clotted blood. Cassimeris et al. [16] showed ¢rst
that thymosin L4 is the main G-actin sequestering peptide in
resting human platelets and later the same group showed that
it is involved in cellular events after activation of platelets [17].
In 1995 Grant et al. reported a 5-fold increase of thymosin
L4 mRNA during morphological di¡erentiation of endothelial
cells into capillary-like tubes [18]. The peptide itself increases
the migration of human umbilical vein endothelial cells 4^6-
fold in vitro and in vivo [19]. Frohm and coworkers reported
high concentrations of thymosin L4 in wound and blister £u-
ids [20]. It was also postulated that L-thymosins may play a
role in apoptosis [21].
Transglutaminases are Ca2-dependent enzymes, which cat-
alyze the posttranslational modi¢cation of proteins through
the exchange of primary amines for ammonia at the carbox-
amide group of glutamine residues. Peptide-bound lysine res-
idues or naturally occurring polyamines serve quite unspeci¢-
cally as primary amine substrates [22,23]. In the case of
peptide-bound lysine residues covalent isopeptide bonds
were formed, which are resistant against proteolysis. Trans-
glutaminases have a broad speci¢city for primary amine sub-
strates, whereas the number of proteins which serve as gluta-
minyl substrates is highly restricted. It is now well established
that transglutaminases are implicated in a wide range of bio-
logical phenomena like blood coagulation (factor XIIIa),
wound healing, terminal di¡erentiation, and apoptosis
[22,23]. Safer et al. described cross-linking of Lys-38 of thy-
mosin L4 to Gln-41 of actin by reaction with transglutaminase
[24]. However, in this transglutamination thymosin L4 served
as an aminyl substrate.
When we further analyzed the possible role of thymosin L4
as a substrate of transglutaminases we found that thymosin L4
was labeled with dansylcadaverine by transglutaminase, hence
reacting as a speci¢c glutaminyl substrate. Here, we describe
the molecular properties of the products formed. Addition-
ally, we show that labeling of thymosin L4 does not interfere
with G-actin-sequestering activity and, therefore, may serve as
a useful tool for further investigations.
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2. Materials and methods
2.1. Materials
Reagents were obtained from the following sources: LiChroprep
RP-18 (40^63 Wm) and tri£uoroacetic acid (TFA, Uvasol) from Merck
(Darmstadt, Germany); 1-ethyl-3-[3-(dimethylamino)propyl]carbodi-
imide (EDC), monodansylcadaverine [N-(5-aminopentyl)-5-(dimethyl-
amino)naphthalene-1-sulfonamide] (DNC), and guinea pig liver trans-
glutaminase from Sigma; AsnC proteinase from PanVera
Corporation (Madison, WI, USA) and trypsin from Boehringer
Mannheim (Mannheim, Germany).
2.2. Proteins and peptides
Actin was prepared from bovine heart or rabbit skeletal muscle by
the method of Pardee and Spudich [25] and further puri¢ed by gel
¢ltration [26] on a Sephacryl S300 column (Pharmacia) equilibrated
with G bu¡er (2 mM Tris^HCl, 0.2 mM ATP, 0.2 mM CaCl2, 0.5
mM mercaptoethanol, 0.05% NaN3, pH 8.0). G-actin was stored in G
bu¡er at 0‡C. Rabbit skeletal muscle actin was pyrenylated following
the procedure given in [27]. Thymosin L4 was isolated from bovine
spleen as described [28]. The purity of the preparations was demon-
strated by reverse phase HPLC. The concentrations of thymosin L4
and actin were determined by amino acid analysis after acid hydro-
lysis (6 M HCl, 155‡C, 1 h) and precolumn derivatization with
o-phthaldialdehyde/3-mercaptopropionic acid [29].
Proteolytic fragments of peptides (thymosin L4 and modi¢ed thy-
mosin L4) were prepared by the following procedures: AsnC endopro-
teinase: 1 Wg of peptide was incubated with 1 Wg protease in 10 Wl
reaction bu¡er (50 mM sodium acetate, pH 5.0, 0.2 mM DTT, 0.2
mM EDTA); trypsin: 50 Wg peptide TG51 was digested with 2 Wg
trypsin in 50 Wl 1% NH4HCO3.
All digestions were incubated for 16 h at room temperature. There-
after, reactions were stopped by adding an equal volume of 10% TFA.
Prior to analysis by MALDI-TOF-MS the samples were concentrated
in vacuo.
2.3. HPLC
Chromatographic conditions were controlled by a Merck-Hitachi
L-6200 system supplemented with a diode array UV detector (L-
7450A, Merck-Hitachi) and with a £uorometer (F-1050, Merck-Hita-
chi). The diode array detector signal was recorded on a computer
using D-7000 HSM software (Merck) and the £uorescence signal on
an integrator (D-2500, Merck-Hitachi). For high sensitivity detection
of peptides, a postcolumn derivatization system was used [30].
Analytical separations. Flow rate: 0.75 ml/min; bu¡er: 0.1% TFA;
gradient: linear from 0 to 40% acetonitrile in 60 min; column: Beck-
man ODS Ultrasphere (5 Wm, 4.6U250 mm); detection: UV at 205
nm or £uorescence after postcolumn derivatization with £uoresc-
amine.
Preparative separation of the peptides. Flow rate: 0.75 ml/min;
bu¡er: 0.1% tri£uoroacetic acid; gradient: linear from 0 to 40% ace-
tonitrile in 120 min; column: Pharmacia SuperPac Pep-S (5 Wm,
4U250 mm); detection: UV (215 nm) or dansyl £uorescence
(Vex = 290 nm, Vem = 540 nm).
2.4. Gel electrophoretic procedures
SDS polyacrylamide gel electrophoresis was performed either by the
method of Laemmli [31] or using Pharmacia PhastGel Gradient 10^
15. Native gel electrophoresis was performed as detailed previously
[32].
2.5. Transglutamination of thymosin L4 with dansylcadaverine
To determine the time course of transglutamination, thymosin L4
(120 WM) was incubated with dansylcadaverine (5 mM) in 70 Wl bu¡er
consisting of 10 mM Tris^HCl, pH 7.4, 15 mM CaCl2, 3 mM DTT.
The reaction was started by addition of 0.1 U transglutaminase. Im-
mediately after addition of the enzyme (t = 0) and at indicated times,
10 Wl were taken from the mixture, diluted in 490 Wl 0.1% TFA to stop
the reaction and analyzed by HPLC.
For preparative separation of labeled peptides, 500 Wg thymosin L4
(200 WM) was incubated at room temperature with 500 Wg dansylca-
daverine (3 mM) and 0.5 U transglutaminase in 500 Wl of the bu¡er
described above. After 1 and 2 h, 10 Wl was subjected to analysis by
HPLC. The reaction was stopped after 4 h by addition of 5 Wl TFA.
Thereafter, the reaction mixture was subjected to preparative HPLC.
Separated peptides were concentrated in vacuo and then characterized
by amino acid analysis and MALDI-TOF mass spectrometry.
2.6. Matrix-assisted laser desorption mass spectrometry
Mass determinations were performed with a Bi£ex1 III MALDI-
TOF mass spectrometer (Bruker Daltonics, Germany). The instru-
ment is equipped with a nitrogen laser (V= 337 nm) and a re£ectron.
Laser-desorbed positive ions were analyzed after being accelerated by
19 kV in the re£ection mode. External calibration was performed by
use of a standard peptide mixture. Usually, 30 individual spectra were
averaged to produce a mass spectrum.
Dried peptide samples were dissolved in 0.1% TFA containing 33%
acetonitrile to a ¢nal concentration of about 20 ng/Wl. Each sample
(1 Wl) was mixed with 2 Wl of a saturated solution of K-cyano-4-hy-
droxycinnamic acid (Sigma, Germany) in 0.1% TFA, 33% acetonitrile
and 1 Wl of this mixture was spotted onto a stainless steel target.
2.7. Viscosimetry and EDC cross-linking
Viscosimetric measurements were done with a falling-ball viscome-
ter according to Cooper and Pollard [33], at an angle of 40‡ relative to
horizontal, distance of fall : 45 mm; ball diameter: 0.794 mm. G-actin
solution (48 Wl ; 0.18 mg/ml in G bu¡er) was incubated with or with-
out thymosin L4 or dansylcadaverine-labeled peptides for 15 min at
room temperature and thereafter 2 Wl 50 mM MgCl2 was added. The
mixture was ¢lled into a glass capillary (diameter 0.92 mm, 50 Wl
micropipettes, Brand No. 708733), sealed at one end and incubated
for 4 h before measuring time of fall. Thereafter, mixtures were re-
moved by centrifugation from the capillaries and incubated with 5 Wl
of an EDC solution (36 mg/ml). After 2 h, an additional 5 Wl EDC
solution was added for another 2 h incubation period. The reaction
mixtures were dialyzed overnight in microcollodion bags (Sartorius)
against G bu¡er. Prior to SDS gel electrophoresis, the solutions were
concentrated in vacuo.
2.8. Transglutamination of thymosin L4 in the presence of G-actin
G-actin and thymosin L4 were incubated with transglutaminase in
the presence or absence of dansylcadaverine in a bu¡er consisting of
10 mM Tris^HCl, pH 8.0, 1 mM CaCl2, 5 mM DTE, 0.5 mM ATP,
0.2 mM NaN3 overnight at room temperature.
3. Results
3.1. Derivatization of thymosin L4 with dansylcadaverine by
transglutaminase
To elucidate whether thymosin L4 could serve as a gluta-
Table 1
Characterization of isolated peptides by MALDI-TOF-MS
Peptide m/z (observed) Composition m/z (calculated) Deviation in x
Thymosin L4 4966.7 [TL4-H] 4964.4 0.46
TG 47 5285.6 [TL4*(DNC)1-H] 5282.8 0.53
TG 48 5286.1 [TL4*(DNC)1-H] 5282.8 0.62
TG 49 5619.3 [TLo4 *(DNC)2-H
] 5617.2 0.37
TG 51 5601.9 [TL4*(DNC)2-H] 5601.2 0.12
TG 55 5919.1 [TL4*(DNC)3-H] 5919.6 0.08
Peptides were isolated by preparative HPLC. Aliquots of the collected fractions were concentrated in vacuo and then applied to MALDI-TOF-
MS.
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minyl substrate for guinea pig transglutaminase we incubated
the peptide with dansylcadaverine, a well-known £uorescent
aminyl substrate of transglutaminase. HPLC analyses taken
directly after addition of the enzyme (t = 0) and after 2 h are
shown in Fig. 1. At the beginning of the reaction (A), the
chromatogram showed a large peak for thymosin L4 and a
very small signal for its sulfoxide (TLo4 ). After 2 h (B), the
amounts of thymosin L4 sulfoxide and thymosin L4 were di-
minished while ¢ve new peaks arose. Because of the presence
of several new peaks we were interested to elucidate which
and whether more than one of the three possible Gln residues
were derivatized. Therefore we measured the kinetics of the
derivatization reaction by HPLC analysis as described in Sec-
tion 2. Fig. 2 shows the time course of the derivatization
reaction, where the amount of thymosin L4 (b) decreased in
a logarithmic manner. The products TG47 (a) and TG48 (F)
increased during the ¢rst 30 min and decreased thereafter. The
third product TG49 (not shown in Fig. 2) increased to the
same extent as thymosin L4 sulfoxide decreased (Fig. 1). Prod-
uct TG51 (R) ¢rst developed nearly parallel to TG47 and
TG48, but increased further and constituted the main prod-
uct. After about 2 h another product (TG55, O) was detected
which was only formed to a small extent during the incuba-
tion period.
3.2. Isolation and characterization of products formed
For isolation and characterization of the products, we car-
ried out the reaction in a preparative manner as described in
Section 2. After preparative HPLC, we isolated six products.
Amino acid analysis of the isolated peptides showed identical
amino acid compositions for all isolated products (data
not shown). The peptides were then characterized by mass
spectroscopy. Table 1 summarizes the observed molecular
masses, assigned molecular formulas, calculated masses and
their deviations. These data showed that there was still
unreacted thymosin L4 (TL4), two mono-DNC derivatives
([TL4*(DNC)1] ; TG47 and TG48), a very low amount of
bis-DNC thymosin L4 sulfoxide ([TL
o
4 *(DNC)2] ; TG49).
In addition to a small amount of tris-DNC thymosin
L4 ([TL4*(DNC)3] ; TG55), a bis-DNC thymosin L4
([TL4*(DNC)2] ; TG51) was identi¢ed as the main product.
3.3. Localization of derivatized Gln residues
To further elaborate which of the three possible Gln resi-
Fig. 1. HPLC analysis of the derivatization of thymosin L4 with
dansylcadaverine by transglutaminase. 10 Wl was taken from the re-
action mixture after incubation for 0 h (A) or 2 h (B). Retention
time (min): thymosin L4 sulfoxide (TL
o
4 , 40.38); thymosin L4 (TL4,
42.95); TG47 (46.47); TG48 (47.57); TG49 (49.01); TG51 (50.72);
TG55 (54.68).
Fig. 2. Time course of the derivatization of thymosin L4 with dan-
sylcadaverine by transglutaminase. At indicated times 10 Wl was tak-
en from the reaction mixture and analyzed by HPLC as described
in Section 2. Symbols: b thymosin L4 ; a TG47; F TG48; R
TG51; O TG55.
Table 2
Characterization of peptide fragments after AsnC digestion by MALDI-TOF-MS
Peptide m/z (observed) Composition m/z (calculated) Deviation in x



















Peptides (1 Wg) were digested with 1 Wg of AsnC proteinase for 16 h at room temperature. Digestion was stopped by adding an equal volume
of 10% TFA. Prior to analysis by MALDI-TOF-MS, samples were dried in vacuo.
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dues were modi¢ed, we digested thymosin L4 as well as pep-
tides TG47, TG48, and TG51 with AsnC proteinase and an-
alyzed the samples by MALDI-TOF-MS. Because thymosin
L4 possesses only one Asn residue, at position 26, this diges-
tion produces two fragments, TL1ÿ264 and TL
27ÿ43
4 , containing
one and two of the Gln residues, respectively. In the case of
thymosin L4, the two expected fragments appeared at molec-
ular masses of 3109.7 (m/z) and 1871.7 (m/z) (Table 2). In the
MALDI mass spectra of digested TG47 the C-terminal frag-
ment was shifted to 2189.6 (m/z), whereas in the case of TG48
the signal for the N-terminal fragment appeared at 3430.8 (m/
z) corresponding to the addition of one DNC (335.5 Da). This
indicated that Gln-23 of TG48 and either Gln-36 or 39 of
TG47 were derivatized. In the case of digested TG51, both
peaks were shifted. Thus, we concluded that Gln-23 and also
one of the two Gln residues close to the C-terminus had been
derivatized in this peptide. To elucidate which of these two
residues was derivatized, we digested TG51 with trypsin.
HPLC analysis of TG51 digested with trypsin yielded two
major and two minor £uorescent peaks (Fig. 3). The two
major peaks were identi¢ed by amino acid analysis and MAL-
DI-TOF-MS as DNC-labeled tryptic fragments TG5119ÿ25 (m/
z = 1181.4; expected 1182.4) and TG5132ÿ38 (m/z = 1194.6; ex-
pected 1195.3). The two minor £uorescent fragments repre-
sented amino acid residues 20^25 (m/z = 1053.3; expected
1054.3) and 20^31 (m/z = 1690.0; expected 1691.0) of TG51.
No DNC-labeled fragment corresponding to TG5139ÿ43 was
detected. Therefore, Gln-36 is the second residue which was
readily modi¢ed by transglutaminase.
3.4. Interaction of modi¢ed thymosin L4 with G-actin
After isolation and characterization of the labeled peptides,
we asked how these modi¢cations of thymosin L4 in£uenced
Fig. 3. HPLC analysis of tryptic fragments of TG51 detected by
dansyl £uorescence.
Fig. 4. Cross-linking of G-actin to thymosin L4 or dansylcadaverine-
labeled peptides by 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide.
Detection was performed by £uorescence (A) or Coomassie blue
staining (B). Lane 1, G-actin and thymosin L4 ; lane 2, G-actin and
TG47; lane 3, G-actin and TG48; lane 4, G-actin and TG51; lane
5, G-actin and TG55. The arrow indicates the position of actin
cross-linked to thymosin L4.
Fig. 5. Transglutamination of thymosin L4 in the presence of G-actin. Detection was performed using either dansylcadaverine £uorescence (A)
or Coomassie blue staining (B). All incubations were done in the presence of 2 WM transglutaminase. Additional conditions were as follows:
Lane 1, G-actin (50 WM) and thymosin L4 (50 WM); lane 2, G-actin (50 WM) and thymosin L4 (100 WM); lane 3, G-actin (50 WM) and dansyl-
cadaverine (100 WM); lane 4, G-actin (50 WM) and dansylcadaverine (250 WM); lane 5, G-actin (50 WM), thymosin L4 (100 WM) and dansylca-
daverine (100 WM).
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the interaction with G-actin. We ¢rst studied the polymeriza-
tion-inhibiting capacity of the peptides using viscosimetry.
The time of fall for polymerized actin was 55 þ 5 s
(means þ S.D., n = 6). In the presence of an equal amount of
thymosin L4, this value decreased to 7 þ 1.5 s (n = 6), which
equaled the value for the bu¡er solution and represented com-
plete inhibition of polymerization. Using equimolar amounts
of thymosin L4 sulfoxide (TL
o
4 ), which is known to inhibit the
polymerization only when present in a 20-fold excess to G-
actin, but not at equimolar concentrations to actin [13], we
determined a value of 40 þ 3 s (n = 4). For all labeled peptides,
values in the range of 7^10 s were determined at equimolar
ratios to G-actin. This indicates that the modi¢cation of nei-
ther a single nor all glutamyl residues of thymosin L4 impaired
the inhibition of the salt-induced polymerization. To verify
these results, we further analyzed the samples by cross-linking
with the zero-length cross-linker EDC and subsequent SDS-
PAGE analysis using Pharmacia PhastGel Gradient 10^15.
Following UV analysis (365 nm) of £uorescent bands (Fig.
4A), gel was stained with Coomassie blue (Fig. 4B). Indeed,
the expected £uorescent bands appeared when actin was cross-
linked with labeled peptides. Coomassie blue staining indi-
cated that all peptides were cross-linked to G-actin to the
same extent. Typically, about 50% of actin was cross-linked
by EDC to L-thymosins.
3.5. Transglutamination of thymosin L4 in the presence of
G-actin
G-actin has been described as a glutaminyl substrate of
transglutaminase [34] and the transglutaminase reaction has
been used to cross-link G-actin and thymosin L4 [24]. There-
fore we studied transglutamination of G-actin in the presence
of thymosin L4 and dansylcadaverine (Fig. 5). Detection of
dansylcadaverine £uorescence after SDS-PAGE (A) showed
that the amount of actin^thymosin L4 crosslink was very
low in the presence of dansylcadaverine and transglutaminase
(lane 5), while there were large amounts of dansylcadaverine-
labeled thymosin L4 (lane 5) and actin (lanes 3^5). Subsequent
Coomassie blue staining (B) demonstrated that actin and thy-
mosin L4 were ine⁄ciently cross-linked by transglutaminase
(lanes 1 and 2). The amount of cross-link further decreased
in the presence of dansylcadaverine competing for Lys resi-
dues of either G-actin or thymosin L4 (100 WM, lane 5). In the
absence of thymosin L4, dansylcadaverine-labeled actin poly-
merized to F-actin as revealed by £uorescence detection after
native PAGE (Fig. 5A, lanes 3 and 4). This was caused by the
calcium concentration needed for activation of transglutami-
nase (1 mM). In contrast, actin polymerization was drastically
inhibited in the presence of 100 WM thymosin L4, due to
complex formation with thymosin L4 (lane 5). Coomassie
blue staining of native gels (Fig. 5B) showed that both G-actin
and its complex with thymosin L4 were present regardless of
whether dansylcadaverine was present or not (lanes 1, 2 and
5).
4. Discussion
In this work, we demonstrated that thymosin L4 could serve
as a glutaminyl substrate for guinea pig liver transglutaminase
at concentrations that are present inside cells. Using proteo-
lytic fragmentation and MALDI-TOF mass spectroscopy, we
elucidated that Gln residues 23 and 36 are easily available for
transglutamination, whereas Gln-39 reacts very slowly and to
a very low extent. Moreover, with this reaction we were able
Fig. 6. Comparison of amino acid sequences of synthetic peptide substrate corresponding to L-casein161ÿ175, thymosin L17ÿ314 , thymosin L
30ÿ43
4 ,
and thymosin L33ÿ434 . Identical amino acids in bold, conservative substitutions in bold italics; ^ , end of sequence; s, Gln residue to be derivat-
ized.
Fig. 7. Amino acid sequences of mammalian L-thymosins. Thymosin L4 (TL4 [4,8]), thymosin LAla4 (TL
Ala
4 [42]), thymosin L9 (TL9 [43]), thymo-
sin LMet9 (TL
Met
9 [28]), thymosin L10 (TL10 [44]), thymosin L15 (TL15 [37], deduced from cDNA sequence). Homologous residues are in bold let-
ters and conservative substitutions around Gln-23 are in bold italics. Substitution of Gln-23 to Glu-23 in thymosin L15 is marked by double
underlining.
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to label thymosin L4 with dansylcadaverine as a £uorescent
marker without abolishing its interaction with G-actin.
The aim of this study was to elucidate whether thymosin L4
could serve as a speci¢c glutaminyl substrate for the trans-
glutaminase reaction. In recent years it has been shown that
thymosin L4 may be involved in cellular events like angiogen-
esis [18,19], wound healing [20], apoptosis [21] and blood co-
agulation [3,16,17]. Because transglutaminases also participate
in all these cellular reactions we investigated whether thymo-
sin L4 and transglutaminase may interact. Our results clearly
show that thymosin L4 could serve as a glutaminyl substrate
for guinea pig transglutaminase at concentrations which are
present inside cells (Fig. 1). Consequently it is likely that
thymosin L4, which is present in human platelets in a concen-
tration of about 500 WM [3,35], serves as a glutaminyl sub-
strate for factor XIIIa.
Our data also verify that not all Gln residues of thymosin
L4 are readily accessible for the transglutaminase reaction.
Gorman and Folk have studied the glutaminyl substrate spe-
ci¢city of factor XIIIa and guinea pig liver transglutaminase
[36]. They performed single and multiple amino acid substitu-
tions of a synthetic peptide substrate corresponding to amino
acid residues 161^175 of L-casein, a well-known substrate for
factor XIIIa (Fig. 6). It was found that substitution of Lys by
a Gly residue at position +2 results in a distinct decrease of its
glutaminyl donor property with transglutaminase, which is
even more pronounced with factor XIIIa. In the case of
Gln-23 and Gln-36 of thymosin L4 a Lys residue follows at
the +2 position, while in the case of Gln-39 a Gly residue is at
this position. This may partly explain why Gln-39 of thymosin
L4 is only labeled to a very low extent. Activity of both en-
zymes showed a distinct or drastic decrease by truncation of
four C- or N-terminal residues. This may be an additional
reason for the low derivatization of Gln-39. The environment
of Gln-23 is highly conserved throughout all mammalian L-
thymosins except thymosin L15 (Fig. 7), which has been de-
scribed to be highly expressed in human cancer cells with high
metastatic activity [37].
Safer et al. [6] proposed that the sequence
17LKKTETQEK25 of thymosin L4 may be involved in actin
sequestering because of its high homology with the well-
known actin-binding sequence of actobindin [38]. In accord-
ance with their proposal, we have previously demonstrated
that truncation of up to 13 N-terminal amino acid residues
does not abolish chemical cross-linking to G-actin, while trun-
cation of the ¢rst 23 amino acid residues completely destroys
interaction [13]. Surprisingly, as demonstrated here, derivati-
zation of Gln-23 with dansylcadaverine did not abolish G-
actin binding, suggesting that this particular position may
not be essential for actin binding. Indeed, Gln-23 is not con-
served in the corresponding sequences of actobindin [38].
There are several reports dealing with G-actin as a gluta-
minyl substrate for the transglutaminase reaction. Takashi has
shown that dansylcadaverine can be cross-linked to Gln-41 of
G-actin and that this leads to a decrease of the critical con-
centration and faster polymerization of labeled G-actin [34]. It
has also been reported that actin from human blood platelets
and rabbit skeletal muscle actin serves as a substrate for fac-
tor XIIIa [39]. Moreover, the cross-linked matrix from plate-
lets formed by the transglutaminase reaction contains actin
[40]. Previously, Nemes et al. [41] have shown that actin seems
to be the main endogenous substrate for tissue transglutami-
nase in HL60 and U937 cells undergoing apoptosis. For de-
tection of substrate proteins, they used a synthetic hapten-
labeled lysine derivative, which is able to cross the cell mem-
brane. After inducing apoptosis, they detected actin as the
major protein transglutaminated with hapten-labeled lysine
by Western blot analysis. Our results prove that, at least
under the conditions used in our assay, thymosin L4 serves
equally well as a substrate for guinea pig transglutaminase
compared to actin (Fig. 5). Because of its low molecular
weight and high solubility thymosin L4 may have escaped
their SDS-PAGE analysis. Therefore, it will be interesting to
look for transglutamination of thymosin L4 during apoptosis
using HPLC techniques.
Taking these data together, it is tempting to speculate that
thymosin L4 may serve as a glutaminyl substrate for trans-
glutaminases in vivo and thus may possibly play an important
role in transglutaminase-related processes.
Acknowledgements: We express our appreciation to Doris Jaegers for
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